The Development and Impact of Hemostatic Stewardship Programs.

Area of Science:

• Hematology
• Pharmacology
• Healthcare Management

Background:

• Recent approvals of novel clotting factor concentrates and anticoagulation antidotes have introduced significant complexities in patient management.
• The increasing availability of these agents necessitates careful consideration of their optimal use to ensure efficacy and safety.
• Rising healthcare costs associated with these advanced therapies underscore the need for efficient resource allocation.

Purpose of the Study:

• To outline a strategic approach for the stewardship of clotting factor concentrates.
• To detail methods for optimizing the use of anticoagulation antidotes.
• To address the increasing complexity and cost of care related to hemostatic agents.

Main Methods:

• Implementation of a multidisciplinary hemostatic stewardship program.
• Development of guidelines for the appropriate selection and administration of clotting factor concentrates.
• Establishment of protocols for the timely and effective use of anticoagulation antidotes.

Main Results:

• Improved utilization of hemostatic resources.
• Enhanced patient safety through appropriate therapy selection.
• Potential for cost savings through optimized drug management.

Conclusions:

• A multidisciplinary hemostatic stewardship program is essential for managing new clotting factor concentrates and anticoagulation antidotes.
• Effective stewardship can mitigate the increased complexity and cost associated with these critical care resources.
• This approach ensures optimal patient outcomes and responsible healthcare resource utilization.